Roche announced this week that the U.S. Food and Drug Administration granted breakthrough therapy designation of obinutuzumab (Gazyva) for lupus nephritis, a major morbidity of systemic lupus erythematosus (SLE).
Investigators are currently pursuing at least 50 possible new treatments, or treatment targets, for systemic lupus and lupus nephritis. We're tracking the studies and in this slideshow, we highlight the results from nine new studies on lupus nephritis.
The U.S. Food and Drug Administration has approved nintedanib (Ofev, Boehringer Ingelheim Pharmaceuticals) capsules to slow the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD), which is a progressive lung disease that can be debilitating and life-threatening.
Levels of the biomarker urine C-telopeptide of cross-linked collagen type II (uCTX-II) are independently associated with radiographic severity and pain intensity in knee osteoarthritis, say researchers writing in Arthritis Research & Therapy this month.
In today's news roundup, we focus on recent advances made in osteoarthritis that touch on cardiovascular issues, bone spurs and treatment modalities.
Rheumatology, the journal of the British Society for Rheumatology, is offering free access (through December 31) to its ten most highly cited papers of 2017 and 2018. In this slideshow, we highlight the 10 most cited articles.
ACR has released the results of a new patient survey that shows one in four patients live with rheumatic disease and although most have health insurance, they still have substantial out of pocket costs. The survey shows that many patents have difficulty getting prescribed medications due to step therapy, a controversial health insurance program that requires patients to use the most cost-effective drug therapy instead of the therapy recommended by their physician.
Patients with rheumatoid arthritis often experience flares when symptoms and functionality worsen. Predicting flares and preventing them is a key area of research in rheumatoid arthrits (RA). In this quiz, test how familiar you are with recent findings in this area.
Men with diabetes may have a higher risk of experiencing chronic lower back pain, say researchers writing in BMJ Open this month.
Nonsteroidal anti-inflammatory drug (NSAID) use contributes substantially to the increased risk of cardiovascular disease among patients with osteoarthritis, say researchers writing in Arthritis & Rheumatology last month.